Abbott Laboratories Company Profile
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of health care products. Co.'s reportable segments include: Established Pharmaceutical Products, which includes a line of generic pharmaceutical products; Nutritional Products, which includes a line of adult and pediatric nutritional products; Diagnostic Products, which includes diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites; and Vascular Products, which includes coronary, endovascular, structural heart, vessel closure and other medical device products. Non-reportable segments include the Diabetes Care and Medical Optics segments.
Address: 100 Abbott Park Road, Abbott Park, IL 60064-6400 | Tel: 224 667-6100 | http://www.abbott.com
Abbott Laboratories Latest News
Abbott reports Q3 net loss of US$329M compared with income of US$580M a year ago, affected by US$947M charge related to adjustment of holdings of Mylan shares; net sales climb 3% to US$5.30B amid growth in medical device, established pharmaceuticalsOct. 19, 2016, Abbott Laboratories
Abbott and St. Jude Medical to sell portion of vascular closure and electrophysiology business to Terumo for about US$1.12B upon completion of Abbott's acquisition of St. Jude MedicalOct. 18, 2016, Abbott Laboratories
Celgene and Agios Pharmaceuticals enter agreements with Abbott to develop and commercialize companion diagnostic tests for acute myeloid leukemia; Celgene and Agios are both currently developing treatments for the illnessOct. 12, 2016, Celgene Corp.
- Revenue 5,333 millions US$
- Earnings 615 millions US$
- EBITDA 871 millions US$
- EBITDA Margin 17.83%
- Latest Quarter April 2016
- Last Updated 2016-10-25
- Country List USA